Stewart Jeffrey Ryan's Form 4 filing
AbbVie Inc. (ABBV) · filed Apr 2, 2025
- Accession no.
- 0001415889-25-009687
- Filed
- Apr 2, 2025
- Trade date
- Mar 31, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $12.4M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Stewart Jeffrey RyanCIK 0001761675 | Officer (EVP, CHIEF COMMERCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | Common Stock, $0.01 par value | MOption exerciseAcquired | +25,700 | $79.02 | +$2,030,814 | 112,066 | Direct | |
| Mar 31, 2025 | Common Stock, $0.01 par value | SSaleDisposed | −25,700 | $209.49 | −$5,383,893 | 86,366 | Direct | |
| Mar 31, 2025 | Common Stock, $0.01 par value | SSaleDisposed | −33,132 | $210.54 | −$6,975,611.28 | 53,234 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | Common Stock | MOption exerciseDisposed | −25,700 | $79.02 | −$2,030,814 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.